Showing results (1-10 of 360) with videos related to
Sort By:
Pageof 36
The Journal of Clinical Psychiatry|March 6, 2007
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trialsJeffrey A LiebermanThe Journal of Clinical Psychiatry|November 17, 2006
Neurobiology and the natural history of schizophreniaJeffrey A LiebermanBrain Research Bulletin|June 20, 2017
The opioid epidemic is an historic opportunity to improve both prevention and treatmentRobert L DuPontJournal of Psychoactive Drugs|July 23, 2010
Prescription drug abuse: an epidemic dilemmaRobert L DuPontJournal of Addiction Medicine|March 17, 2017
"Should Patients With Substance Use Disorders Be Prescribed Benzodiazepines?" NoRobert L DuPontPsychological Medicine|October 27, 2017
Alive but not well: the limited validity but continued utility of the concept of schizophreniaAnthony W Zoghbi, Jeffrey A LiebermanThe Journal of Clinical Psychiatry|March 6, 2007
Cost-effectiveness measures, methods, and policy implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for schizophreniaRobert A Rosenheck, Jeffrey A LiebermanThe Journal of Clinical Psychiatry|March 29, 2007
Comparing safety and tolerability of antipsychotic treatmentJohn W Newcomer, Jeffrey A LiebermanPageof 36